Maartje E. Visser

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia

Christopher T. Johansen, Jian Wang, Matthew B. Lanktree et al. · Nature Genetics · 2010 · 444 citations

Life Sciences, Genetics, Molecular Genetics +14

Mutations in <i>LPL</i>, <i>APOC2</i>, <i>APOA5</i>, <i>GPIHBP1</i> and <i>LMF1</i> in patients with severe hypertriglyceridaemia

Ramya Preethi Surendran, Maartje E. Visser, Steffie Heemelaar et al. · Journal of Internal Medicine · 2012 · 246 citations

Life Sciences, Genetics, Molecular Genetics +17

Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial

Maartje E. Visser, Gilbert Wagener, Brenda F. Baker et al. · European Heart Journal · 2012 · 190 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia

Fatima Akdim, Maartje E. Visser, Diane L. Tribble et al. · The American Journal of Cardiology · 2010 · 179 citations

Life Sciences, Pharmacology, Pharmacotherapy +13

Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia

Maartje E. Visser, Fatima Akdim, Diane L. Tribble et al. · Journal of Lipid Research · 2009 · 111 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17